Close
Nordic 9Nordic 9

Fundplus (investor - Venture Capital)

Belgium fundplus.be
See something wrong or missing? Let us know
Offices:Leuven
Average round investment:48.75M USD
Average number per year:3.0
Distribution: 2024 (3)2022 (3)2021 (4)2020 (4)2019 (1)
Portfolio companies: France Coave TherapeuticsBelgium Confo TherapeuticsGermany Tubulis See the entire list
Mostly invests in: Belgium Belgium (8) Health services (15)
See the entire list

Showing 3 of 15 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Fundplus mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Fundplus

Name Criteria
France Turenne Capital Partenaires
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Germany Bastian Nominacher
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Belgium SFPI-FPIM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, France, Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Benhamou Global Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, France, Netherlands, Spain
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United States Accenture
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Luxembourg 3B Future Health Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium BNP Paribas Fortis Private Equity
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France CPH Banque
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Arab Emirates CE-Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Rubin Ritter
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top